Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 3, 2015, Pages 680-685

  Brandis, Gerrit ^a   Pietsch, Franziska ^a   Alemayehu, Rahel ^a   Hughes, Diarmaid ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

M. tuberculosis; Resistance genetics; RifR

Indexed keywords

RIFAMPICIN; RNA POLYMERASE; ANTIINFECTIVE AGENT; DNA DIRECTED RNA POLYMERASE; RNA POLYMERASE BETA SUBUNIT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATION; BETA CHAIN; DNA SEQUENCE; GENE AMPLIFICATION; GENETIC RESISTANCE; MINIMUM INHIBITORY CONCENTRATION; MORPHOLOGICAL TRAIT; MUTATION RATE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; SALMONELLA; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR EVOLUTION; MUTATION; NUCLEOTIDE SEQUENCE; TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; DNA MUTATIONAL ANALYSIS; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; EVOLUTION, MOLECULAR; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; MUTATION RATE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; SALMONELLA TYPHIMURIUM; TUBERCULOSIS;

EID: 84928190938     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku434     Document Type: Article

References (28)

1. Diacon AH, Groote-Bidlingmaier von F, Donald PR. From magic mountain to table mountain. Swiss Med Wkly 2012; 142: w13665.
2. Artsimovitch I, Vassylyev DG. Is it easy to stop RNA polymerase?. Cell Cycle 2006; 5: 399-404.
3. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 1998; 79: 3-29.
4. Campbell EA, Korzheva N, Mustaev A et al. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 2001; 104: 901-12.
5. Heep M, Brandstatter B, Rieger U et al. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol 2001; 39: 107-10.
6. Bottger EC, Springer B, Pletschette M et al. Fitness of antibioticresistant microorganisms and compensatory mutations. Nat Med 1998; 4: 1343-4.
7. Sander P, Springer B, Prammananan Tet al. Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob Agents Chemother 2002; 46: 1204-11.
8. Gagneux S. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 2006; 312: 1944-6.
9. Billington OJ, McHugh TD, Gillespie SH. Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob Agents Chemother 1999; 43: 1866-9.
10. Mariam DH, Mengistu Y, Hoffner SE et al. Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2004; 48: 1289-94.
11. Shcherbakov D, Akbergenov R, Matt T et al. Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis. Molecular Microbiology 2010; 77: 830-40.
12. Ellis HM, Yu D, DiTizio T. High efficiency mutagenesis, repair, and engineering of chromosomal DNA using single-stranded oligonucleotides. Proc Natl Acad Sci USA 2001; 98: 6742-6.
13. Brandis G, Wrande M, Liljas L et al. Fitness-compensatory mutations in rifampicin-resistant RNA polymerase. Mol Microbiol 2012; 85: 142-51.
14. Dykhuizen DE. Experimental studies of natural selection in bacteria. Ann Rev Ecol Syst 1990; 21: 373-98.
15. Rahmo A, Hamdar Z, Kasaa I et al. Genotypic detection of rifampicinresistant M. tuberculosis strains in Syrian and Lebanese patients. J Infect Public Health 2012; 5: 381-7.
16. Tang K, Sun H, Zhao Y et al. Characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Sichuan in China. Tuberculosis (Edinb) 2013; 93: 89-95.
17. Rahim Z, Nakajima C, Raqib R et al. Molecular mechanism of rifampicin and isoniazid resistance in Mycobacterium tuberculosis from Bangladesh. Tuberculosis (Edinb) 2012; 92: 529-34.
18. Jnawali HN, Hwang SC, Park YK et al. Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea. Diagn Microbiol Infect Dis 2013; 76: 187-96.
19. Casali N, Nikolayevskyy V, Balabanova Y et al. Microevolution of extensively drug-resistant tuberculosis in Russia. Genome Res 2012; 22: 735-45.
20. Farhat MR, Shapiro BJ, Kieser KJ et al. Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis. Nat Genet 2013; 45: 1183-9.
21. Zhang H, Li D, Zhao L et al. Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance. Nat Genet 2013; 45: 1255-60.
22. Brandis G, Hughes D. Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates. J Antimicrob Chemother 2013; 68: 2493-7.
23. Song T, Park Y, Shamputa IC et al. Fitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the b′ subunit of RNA polymerase. Mol Microbiol 2014; 91: 1106-19.
24. Comas I, Borrell S, Roetzer A et al. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat Genet 2011; 44: 106-10.
25. Jarvik T, Smillie C, Groisman EA et al. Short-term signatures of evolutionary change in the Salmonella enterica serovar Typhimurium 14028 genome. J Bacteriol 2009; 192: 560-7.
26. Garibyan L, Huang T, KimMet al. Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome. DNA Repair 2003; 2: 593-608.
27. Minh NN, Van Bac N, Son NTet al. Molecular characteristics of rifampinand isoniazid-resistant Mycobacterium tuberculosis strains isolated in Vietnam. J Clin Microbiol 2012; 50: 598-601.
28. Titov LP, Zakerbostanabad S, Slizen V et al. Molecular characterization of rpoB gene mutations in rifampicine-resistant Mycobacterium tuberculosis isolates fromtuberculosis patients in Belarus. Biotechnol J 2006; 1: 1447-52.